VT News
Carl Hayman

Carl Hayman

Ask VT AI
View News Summary
  • Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
  • Controversial Israeli bills aim to halt Netanyahu's trial and block Bennett's election bid, sparking concerns over democracy and rule of law.
  • Bills rout Panthers 40-9 behind James Cook's career-high 216 rushing yards and two touchdowns.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
  • Controversial Israeli bills aim to halt Netanyahu's trial and block Bennett's election bid, sparking concerns over democracy and rule of law.
  • Bills rout Panthers 40-9 behind James Cook's career-high 216 rushing yards and two touchdowns.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Carl Hayman

Top Topics

Trending in U.S.

World

Sport